Search
01/11/2022
New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia
del Campo, M, Zetterberg, H, Gandy, S, Onyike, CU, Oliveira, F, Udeh-Momoh, C, Lleo, A, Teunissen, CE, Pijnenburg, Y. New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2022; 18(11)DOI:10.1002/alz.12643. PMID:35235699. IF:14.000(Q1/1D).
01/07/2024
Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview
Badhwar, A, Hirschberg, Y, Valle-Tamayo, N, Iulita, MF, Udeh-Momoh, CT, Matton, A, Tarawneh, RM, Rissman, RA, Ledreux, A, Winston, CN, Haqqani, AS. Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview. ALZHEIMERS & DEMENTIA. 2024; 20(7)DOI:10.1002/alz.13823. PMID:38864416. IF:11.100(Q1/1D).
11/04/2023
Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome
Videla L., Benejam B., Carmona-Iragui M., Barroeta I., Fernández S., Arranz J., Azzahchi S.E., Altuna M., Padilla C., Valldeneu S., Pegueroles J., Montal V., Aranha M.R., Vaqué-Alcázar L., Iulita M.F., Alcolea D., Bejanin A., Videla S., Blesa R., Lleó A., Fortea J.. Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2023; 19(9)DOI:10.1002/alz.13073. PMID:37038748. IF:13.100(Q1/1D).
06/04/2023
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome
Aranha, MR, Iulita M.F., Montal V., Pegueroles J., Bejanin A., Vaqué-Alcázar L., Grothe M.J., Carmona-Iragui M., Videla L., Benejam B., Arranz J., Padilla C., Valldeneu S., Barroeta I., Altuna M., Fernández S., Ribas L., Valle-Tamayo N., Alcolea D., González-Ortiz S., Bargalló N., Zetterberg H., Blennow K., Blesa R., Wisniewski T., Busciglio J., Cuello A.C., Lleó A., Fortea J.. Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2023; 19(11)DOI:10.1002/alz.12999. PMID:37021589. IF:13.100(Q1/1D).
01/06/2025
Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers
Barroeta, I, Videla, L, Carmona-Iragui, M, Fortea, J, Rafii, MS. Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70258. PMID:40528298. IF:11.100(Q1/1D).
01/06/2025
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome
Sauer, M, Gomes, BF, Shahrouki, P, Lantero-Rodriguez, J, Montoliu-Gaya, L, Camporesi, E, Belbin, O, Alcolea, D, Kumar, A, Sharma, M, Singh, S, Brinkmalm, G, Gobom, J, Carmona-Iragui, M, Schöll, M, Janelidze, S, Deep, G, Blennow, K, Zetterberg, H, Brinkmalm, A, Lleó, A, Fortea, J, Hansson, O, Ashton, NJ, Nilsson, J. Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70241. PMID:40522075. IF:11.100(Q1/1D).